-DOCSTART- -X- O
Immunological -X- _ O
checkpoints -X- _ O
, -X- _ O
such -X- _ O
as -X- _ O
the -X- _ O
inhibitory -X- _ B-Intervention
CD200 -X- _ I-Intervention
receptor -X- _ I-Intervention
( -X- _ I-Intervention
CD200R -X- _ I-Intervention
) -X- _ I-Intervention
, -X- _ O
play -X- _ O
a -X- _ O
dual -X- _ O
role -X- _ O
in -X- _ O
balancing -X- _ O
the -X- _ O
immune -X- _ O
system -X- _ O
during -X- _ O
microbial -X- _ O
infection. -X- _ O
On -X- _ O
the -X- _ O
one -X- _ O
hand -X- _ O
these -X- _ O
inhibitory -X- _ O
signals -X- _ O
prevent -X- _ O
excessive -X- _ O
immune -X- _ O
mediated -X- _ O
pathology -X- _ O
but -X- _ O
on -X- _ O
the -X- _ O
other -X- _ O
hand -X- _ O
they -X- _ O
may -X- _ O
impair -X- _ O
clearance -X- _ O
of -X- _ O
the -X- _ O
pathogen. -X- _ O
We -X- _ O
studied -X- _ O
the -X- _ O
influence -X- _ O
of -X- _ O
the -X- _ O
inhibitory -X- _ B-Intervention
CD200-CD200R -X- _ I-Intervention
axis -X- _ O
on -X- _ O
clearance -X- _ O
and -X- _ O
pathology -X- _ O
in -X- _ O
two -X- _ O
different -X- _ O
virus -X- _ O
infection -X- _ O
models. -X- _ O
We -X- _ O
find -X- _ O
that -X- _ O
lack -X- _ B-Outcome
of -X- _ I-Outcome
CD200R -X- _ I-Outcome
signaling -X- _ I-Outcome
strongly -X- _ I-Outcome
enhances -X- _ I-Outcome
type -X- _ I-Outcome
I -X- _ I-Outcome
interferon -X- _ I-Outcome
( -X- _ I-Outcome
IFN -X- _ I-Outcome
) -X- _ I-Outcome
production -X- _ I-Outcome
and -X- _ I-Outcome
viral -X- _ I-Outcome
clearance -X- _ I-Outcome
and -X- _ I-Outcome
improves -X- _ I-Outcome
the -X- _ I-Outcome
outcome -X- _ I-Outcome
of -X- _ I-Outcome
mouse -X- _ I-Outcome
hepatitis -X- _ I-Outcome
corona -X- _ I-Outcome
virus -X- _ I-Outcome
( -X- _ I-Outcome
MHV -X- _ I-Outcome
) -X- _ I-Outcome
infection -X- _ I-Outcome
, -X- _ O
particularly -X- _ O
in -X- _ O
female -X- _ B-Patient
mice. -X- _ I-Patient
MHV -X- _ O
clearance -X- _ O
is -X- _ O
known -X- _ O
to -X- _ O
be -X- _ O
dependent -X- _ O
on -X- _ O
Toll -X- _ O
like -X- _ O
receptor -X- _ O
7 -X- _ O
( -X- _ O
TLR7 -X- _ O
) -X- _ O
-mediated -X- _ O
type -X- _ O
I -X- _ O
IFN -X- _ O
production -X- _ O
and -X- _ O
sex -X- _ O
differences -X- _ O
in -X- _ O
TLR7 -X- _ O
responses -X- _ O
previously -X- _ O
have -X- _ O
been -X- _ O
reported -X- _ O
for -X- _ O
humans. -X- _ O
We -X- _ O
therefore -X- _ O
hypothesize -X- _ O
that -X- _ O
CD200R -X- _ B-Outcome
ligation -X- _ I-Outcome
suppresses -X- _ I-Outcome
TLR7 -X- _ I-Outcome
responses -X- _ I-Outcome
and -X- _ I-Outcome
that -X- _ I-Outcome
release -X- _ I-Outcome
of -X- _ I-Outcome
this -X- _ I-Outcome
inhibition -X- _ I-Outcome
enlarges -X- _ I-Outcome
sex -X- _ I-Outcome
differences -X- _ I-Outcome
in -X- _ I-Outcome
TLR7 -X- _ I-Outcome
signaling. -X- _ I-Outcome
This -X- _ O
hypothesis -X- _ O
is -X- _ O
supported -X- _ O
by -X- _ O
our -X- _ O
findings -X- _ O
that -X- _ O
in -X- _ B-Outcome
vivo -X- _ I-Outcome
administration -X- _ I-Outcome
of -X- _ I-Outcome
synthetic -X- _ I-Outcome
TLR7 -X- _ I-Outcome
ligand -X- _ I-Outcome
leads -X- _ I-Outcome
to -X- _ I-Outcome
enhanced -X- _ I-Outcome
type -X- _ I-Outcome
I -X- _ I-Outcome
IFN -X- _ I-Outcome
production -X- _ I-Outcome
, -X- _ I-Outcome
particularly -X- _ I-Outcome
in -X- _ I-Outcome
female -X- _ I-Outcome
Cd200 -X- _ I-Outcome
( -X- _ I-Outcome
− -X- _ I-Outcome
/ -X- _ I-Outcome
− -X- _ I-Outcome
) -X- _ I-Outcome
mice -X- _ I-Outcome
and -X- _ I-Outcome
that -X- _ I-Outcome
CD200R -X- _ I-Outcome
ligation -X- _ I-Outcome
inhibits -X- _ I-Outcome
TLR7 -X- _ I-Outcome
signaling -X- _ I-Outcome
in -X- _ I-Outcome
vitro. -X- _ I-Outcome
In -X- _ I-Outcome
influenza -X- _ I-Outcome
A -X- _ I-Outcome
virus -X- _ I-Outcome
infection -X- _ I-Outcome
we -X- _ I-Outcome
show -X- _ I-Outcome
that -X- _ I-Outcome
viral -X- _ I-Outcome
clearance -X- _ I-Outcome
is -X- _ I-Outcome
determined -X- _ I-Outcome
by -X- _ I-Outcome
sex -X- _ I-Outcome
but -X- _ I-Outcome
not -X- _ I-Outcome
by -X- _ I-Outcome
CD200R -X- _ I-Outcome
signaling. -X- _ I-Outcome
However -X- _ O
, -X- _ O
absence -X- _ B-Outcome
of -X- _ I-Outcome
CD200R -X- _ I-Outcome
in -X- _ I-Outcome
influenza -X- _ I-Outcome
A -X- _ I-Outcome
virus -X- _ I-Outcome
infection -X- _ I-Outcome
results -X- _ I-Outcome
in -X- _ I-Outcome
enhanced -X- _ I-Outcome
lung -X- _ I-Outcome
neutrophil -X- _ I-Outcome
influx -X- _ I-Outcome
and -X- _ I-Outcome
pathology -X- _ I-Outcome
in -X- _ I-Outcome
females. -X- _ I-Outcome
Thus -X- _ I-Outcome
, -X- _ I-Outcome
CD200-CD200R -X- _ I-Outcome
and -X- _ I-Outcome
sex -X- _ I-Outcome
are -X- _ I-Outcome
host -X- _ I-Outcome
factors -X- _ I-Outcome
that -X- _ I-Outcome
together -X- _ I-Outcome
determine -X- _ I-Outcome
the -X- _ I-Outcome
outcome -X- _ I-Outcome
of -X- _ I-Outcome
viral -X- _ I-Outcome
infection. -X- _ I-Outcome
Our -X- _ O
data -X- _ O
predict -X- _ O
a -X- _ O
sex -X- _ O
bias -X- _ O
in -X- _ O
both -X- _ O
beneficial -X- _ O
and -X- _ O
pathological -X- _ O
immune -X- _ O
responses -X- _ O
to -X- _ O
virus -X- _ O
infection -X- _ O
upon -X- _ O
therapeutic -X- _ O
targeting -X- _ O
of -X- _ O
CD200-CD200R -X- _ B-Intervention
. -X- _ O

